This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This NAP1L3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 432-459 amino acids from the C-terminal region of human NAP1L3.
NAP1L3
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
FITC
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
NAP1L3
(Nucleosome Assembly Protein 1-Like 3 (NAP1L3))
MB20 antikoerper, NPL3 antikoerper, nucleosome assembly protein 1 like 3 antikoerper, nucleosome assembly protein 1-like 3 antikoerper, NAP1L3 antikoerper, Nap1l3 antikoerper
Hintergrund
This gene encodes a member of the nucleosome assembly protein (NAP) family. It is linked closely to a region of genes responsible for several X-linked mental retardation syndromes. Alternatively spliced transcript variants have been found for this gene, but the biological validity of the variants has not been determined.